ID: ALA4648520

Max Phase: Preclinical

Molecular Formula: C4H8FNO2

Molecular Weight: 121.11

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  NC[C@H](F)CC(=O)O

Standard InChI:  InChI=1S/C4H8FNO2/c5-3(2-6)1-4(7)8/h3H,1-2,6H2,(H,7,8)/t3-/m1/s1

Standard InChI Key:  UNJUEKLVLCDYIR-GSVOUGTGSA-N

Associated Targets(non-human)

Gamma-amino-N-butyrate transaminase 192 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 121.11Molecular Weight (Monoisotopic): 121.0539AlogP: -0.24#Rotatable Bonds: 3
Polar Surface Area: 63.32Molecular Species: ZWITTERIONHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.06CX Basic pKa: 8.93CX LogP: -2.92CX LogD: -2.92
Aromatic Rings: 0Heavy Atoms: 8QED Weighted: 0.54Np Likeness Score: 0.16

References

1. Johnson BM, Shu YZ, Zhuo X, Meanwell NA..  (2020)  Metabolic and Pharmaceutical Aspects of Fluorinated Compounds.,  63  (12): [PMID:32182061] [10.1021/acs.jmedchem.9b01877]

Source